The health care industry is gearing up for a battle over whether and how clinical artificial intelligence should get paid for. 

As of the end of September, the Food and Drug Administration has authorized 1,357 AI-enabled medical devices. But very few of those tools are actively paid for by insurers. 

Some health policy experts and clinicians don’t see that as a problem.

Continue to STAT+ to read the full story…